Evonik opens China API facility

Evonik has started production at its new API facility in Nanning, China. The 70m³ capacity plan, which can be doubled in size if required, will primarily supply the Chinese market. The plant has been set up in collaboration with a European pharmaceutical company for which Evonik will produce various active ingredients under a multi-year supply contract and in compliance with cGMP.
Evonik